...a competitive enzymeimmunoassay (EIA) for the quan...or rat serum or plasma. Corticosterone is the majo...nd in most non-mammalian vertebrates such as amphi... corticosterone and cortisol, in varying proportio...
...assay system for the measurement of 1,25-dihydroxy...ssay incorporates the same award-winning immunoext... by quantitation by convenient enzymeimmunoassay. ...anic or solvent waste disposal is required. The ki...
Mouse Anti-Drosophila fasciclin III Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Sheep Anti-Salmonella Shoreditch Polyclonal Antibody, Unconjugated from Abcam
Biology Products:(Date:11/25/2009)...RNewswire/ -- Research Triangle Park-based Cnanoz ...reatment water purification system NanoPure(TM) de...inister of Rural Water Supply, Hon. Minister Viswa...nitial tests, performed at Indian Institute of Tec...of the drinking water available in India contains ...
(Date:11/25/2009)...RNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a ...ced today that it executed,a joint venture (JV) ag...nology Co., Ltd. (Sinovac Dalian). The JV will res...e vaccines. Sinovac will contribute its expertise,...orld-class vaccines; the,other party will bring it...
(Date:11/24/2009)...so Visit Detroit , (Vocus...ch Ambassador for International Investment, and Ch..., , ,What: Ambassador Appia is available to meet w...es adopted by France to further develop the financ...and development., , ,When: Available for Interview...
(Date:11/24/2009)...ire-FirstCall/ -- Sigma-Aldrich Corporation (Nasda...nference on Tuesday, December 1st at 1:45 PM GMT i...isten via live audio broadcast over the Internet a...rich.com/ . Users can click the "Webcast" icon t... Sigma-Aldrich is a leading Life Science and Hig...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3